Colon cancer: surgical therapy

Area of Science:

• Oncology
• Surgical Oncology
• Gastrointestinal Cancer Research

Background:

• Colorectal carcinoma treatment relies heavily on surgical resection of primary tumors and regional lymph nodes.
• A substantial number of patients achieve successful outcomes post-surgery, even with lymph node involvement, suggesting localized disease confinement.
• However, approximately 50% of patients experience cancer recurrence, with limited salvage options.

Purpose of the Study:

• To evaluate the effectiveness of surgical resection in treating colon cancer.
• To analyze recurrence rates and outcomes in patients undergoing surgical treatment for colorectal carcinoma.
• To highlight the limitations of current non-surgical therapeutic options for recurrent disease.

Main Methods:

• Review of surgical outcomes for colon cancer patients.
• Analysis of recurrence data following primary lesion and lymph node resection.
• Assessment of survival rates for patients with recurrent colorectal carcinoma.

Main Results:

• Surgical resection is a cornerstone of colon cancer treatment, leading to no recurrence in a significant patient cohort.
• Cancer recurrence occurs in about half of the patients treated surgically.
• Recurrent colorectal carcinoma has a poor prognosis, with limited curative options outside of re-operation.

Conclusions:

• Surgical intervention is critical for localized colon cancer but does not eliminate the risk of recurrence.
• The high mortality rate associated with recurrent colorectal carcinoma underscores the need for improved non-surgical therapeutic strategies.
• Current non-surgical therapies offer minimal curative potential for advanced or recurrent colorectal cancer.